Xeris Biopharma Holdings, Inc. (XERS)

5.94 -0.08 (-1.33%) USD  |  NASDAQ  |  Mar 03, 16:00
6.04 +0.10 (+1.68%) Pre-Market: 08:11
More

Xeris Biopharma Holdings Stock Based Compensation (5 Year Growth)

Stock Based Compensation (5 Year Growth) Chart

View Stock Based Compensation (5 Year Growth) for XERS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (5 Year Growth) Range, Past 5 Years

View Stock Based Compensation (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (5 Year Growth) Benchmarks

View Stock Based Compensation (5 Year Growth) Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
IDEXX Laboratories, Inc. Upgrade
Harrow, Inc. Upgrade
Vir Biotechnology, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade